Table 1 Genotype, group size, gender, and age of the mice utilized in the current study
From: Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Treatment group | Group size (n) | Gender |
|---|---|---|
20-month hTau + Veh | 12 | 10 female |
2 male | ||
20-month hTau + SB239063 | 4 | 4 female |
20-month hTau + MW181 | 8 | 6 female |
2 male | ||
6-month hTau + Veh | 3 | 1 male |
2 female | ||
6-month hTau + MW181 | 4 | 1 male |
3 female | ||
6-month C57BL/6 J (non-Tg) | 3 | 3 male |
2-month-old MK2–/– + Veh | 3 | 3 male |
2-month-old MK2–/– + LPS | 4 | 4 male |
2-month-old C57BL/6 J (non-Tg) + Veh | 3 | 3 male |
2-month-old C57BL/6 J (non-Tg) + LPS | 4 | 4 male |